doxazosin

Generic: doxazosin

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin
Labeler rising pharma holdings, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 8 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 16571-168
Product ID 16571-168_c7ae6273-26c7-4116-a42a-5c82e1b59849
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212727
Listing Expiration 2026-12-31
Marketing Start 2024-05-20

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16571168
Hyphenated Format 16571-168

Supplemental Identifiers

RxCUI
197625 197626 197627 197628
UPC
0316571168019
UNII
86P6PQK0MU

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin (source: ndc)
Application Number ANDA212727 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 8 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (16571-168-01)
source: ndc

Packages (1)

16571-168-01 100 TABLET in 1 BOTTLE (16571-168-01)

Ingredients (1)

doxazosin mesylate (8 mg/1)

Linked Drug Pages (1)

Doxazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c7ae6273-26c7-4116-a42a-5c82e1b59849", "openfda": {"upc": ["0316571168019"], "unii": ["86P6PQK0MU"], "rxcui": ["197625", "197626", "197627", "197628"], "spl_set_id": ["508b908e-8d80-422e-8ec0-2081185f4c95"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (16571-168-01)", "package_ndc": "16571-168-01", "marketing_start_date": "20240520"}], "brand_name": "Doxazosin", "product_id": "16571-168_c7ae6273-26c7-4116-a42a-5c82e1b59849", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "16571-168", "generic_name": "Doxazosin", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "8 mg/1"}], "application_number": "ANDA212727", "marketing_category": "ANDA", "marketing_start_date": "20240520", "listing_expiration_date": "20261231"}